The minimum purchase order quantity for the product is 1
Dasatinib is approved as a cancer medication, but recent attention has been focused on its ability to act as a senolytic; that is an agent that can remove ‘dead’ (senscent) cells within the body by inducing a process known as autophagy.
There is no doubt that dasatinib represents the cutting-edge in anti-aging medicine, perhaps even experimental in some respects, but hardcore enthusiasts are aware that senolytics are presently a major focus of research.
The current program is considered to be as follows:
A dose of 5 mg per Kg body weight (2.2 lbs). This dose should be divided into two and taken at least a week apart and does not need to be cycled again for 8 to 12 months.
Example: if you weigh 72 Kg (158 lbs) then the total dose is 72x 5 = 360 mg.
Divide into two 360/ 2 = 180 mg so that’s the dose for week one and again in week two.
Remember that once completed, this dose does not need to be cycled again for 8 to 12 months.